SUCAMPO PHARMACEUTICALS INC's ticker is and the CUSIP is 864909AA4. A total of 28 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $2,732,000 | +32.2% | 2,250,000 | +12.5% | 0.02% | +33.3% |
| Q3 2017 | $2,066,000 | +5.8% | 2,000,000 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $1,953,000 | -1.3% | 2,000,000 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $1,979,000 | -7.1% | 2,000,000 | 0.0% | 0.01% | -7.7% |
| Q4 2016 | $2,130,000 | – | 2,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Southpaw Asset Management LP | 19,125,000 | $19,737,000 | 20.17% |
| Mohican Financial Management, LLC | 2,250,000 | $2,342,000 | 4.50% |
| Context Capital Management, LLC | 3,000,000 | $3,101,000 | 2.08% |
| Wellesley Asset Management | 35,006 | $36,341,000 | 1.95% |
| LINDEN ADVISORS LP | 32,639,000 | $33,765,000 | 1.20% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 35,000,000 | $36,200,000 | 0.54% |
| AQR Arbitrage LLC | 34,050,000 | $35,348,000 | 0.38% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 9,835,000 | $10,160,000 | 0.35% |
| WOLVERINE ASSET MANAGEMENT LLC | 25,196,000 | $26,170,000 | 0.29% |
| UBS OCONNOR LLC | 16,000,000 | $16,561,000,000 | 0.24% |